ITGB2 and familial pancreatic carcinoma: On the basis of our in vitro experiments we sought to test the effects of canertinib on tumorigenicity and metastasis using the in vivo pancreatic cancer orthotopic model (CD18/HPAF luciferase tagged pancreatic cancer cells).